- Home
- LCNB vs SRZN Comparison
LCNB vs SRZN Comparison
Compare LCNB & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LCNB | SRZN |
|---|---|---|
| Founded | 1877 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.9M | 276.3M |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LCNB | SRZN |
|---|---|---|
| Price | $19.77 | $29.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $20.83 | ★ $47.50 |
| AVG Volume (30 Days) | 20.4K | ★ 509.7K |
| Earning Date | 10-15-2026 | 11-10-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 68.04 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $6,445,000.00 | $3,477,000.00 |
| Revenue This Year | $11.08 | $208.89 |
| Revenue Next Year | $0.51 | N/A |
| P/E Ratio | $23.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.83 | $11.39 |
| 52 Week High | $21.32 | $37.83 |
Technical Indicators
Market Signals| Indicator | LCNB | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 60.98 | 56.57 |
| Support Level | $18.44 | $24.16 |
| Resistance Level | $20.29 | $30.19 |
| Average True Range (ATR) | 0.51 | 2.07 |
| MACD | 0.11 | 0.31 |
| Stochastic Oscillator | 90.57 | 68.56 |
Price Performance
Historical ComparisonAbout LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).